Your cart is empty.
Keep shopping
Teach on Udemy
Turn what you know into an opportunity and reach millions around the world.
Learn MoreCell Injury, Adaptation & Death: Pathology Made Clear
Cell Injury, Adaptation & Death: Pathology Made Clear
Master cellular responses to stress, the mechanisms of injury, and the morphology of necrosis and apoptosis
Role Play
Created byISO Horizon
Last updated 6/2026
English
What you'll learn
- Differentiate the four cellular adaptations — hypertrophy, hyperplasia, atrophy, and metaplasia — by mechanism and clinical context
- Distinguish hypoxia from ischemia and predict how each evolves toward reversible or irreversible injury
- Trace the molecular mechanisms of cell injury through ATP depletion, oxidative stress, calcium overload, and protein misfolding
- Recognize coagulative, liquefactive, caseous, gangrenous, fat, and fibrinoid necrosis on gross and microscopic examination
- Compare the intrinsic and extrinsic pathways of apoptosis and the roles of BCL-2 family proteins and caspases
- Identify autophagy, necroptosis, pyroptosis, and ferroptosis as distinct regulated cell death programs
- Interpret intracellular accumulations of lipids, proteins, glycogen, and pigments as fingerprints of specific diseases
- Differentiate dystrophic from metastatic calcification by setting and clinical implications
- Correlate serum biomarkers of cell death with the morphologic timeline of injury in specific organs
- Apply the framework of adaptation, injury, and death to reason through any pathologic process
Explore related topics
Course content
22 sections • 30 lectures
- Introduction to Cellular Adaptation: When Cells Change to Survive6:50Welcome to the fascinating world of cellular adaptation, where you will learn how cells respond to physiologic and pathologic stress by altering their size, number, phenotype, metabolic activity, or function to maintain homeostasis. This lecture frames the four major adaptive responses — hypertrophy, hyperplasia, atrophy, and metaplasia — as a spectrum of reversible changes that sit between the healthy baseline and the point of no return where injury and death begin. You will explore the conceptual continuum from adaptation to reversible injury to irreversible injury, anchored by everyday clinical examples such as the bulked-up cardiac muscle of an athlete, the enlarged uterus during pregnancy, the shrunken muscles of a bedridden patient, and the transformed esophageal lining in chronic reflux. Expect to leave with a clear mental model of why adaptations exist, when they tip over into disease, and how recognizing them on histology and imaging helps you reason about underlying pathology.
- Hypertrophy: Physiologic and Pathologic Cell Enlargement8:36Hypertrophy is the increase in cell size, and therefore organ size, driven by enhanced synthesis of structural proteins and organelles rather than by cell division. In this lecture you will learn the molecular triggers — mechanical stretch, growth factors such as IGF-1, alpha-adrenergic agonists, and vasoactive agents like angiotensin II and endothelin-1 — and the downstream signaling cascades involving PI3K/AKT and G-protein coupled pathways that converge on transcription factors such as GATA4, NFAT, and MEF2 to induce a fetal gene program. You will compare physiologic hypertrophy, exemplified by skeletal muscle in weight lifters and the gravid uterus under estrogen stimulation, with pathologic hypertrophy of the pressure-overloaded left ventricle in hypertension or aortic stenosis. The lecture explains why hypertrophy ultimately fails — limits of vascular supply, mitochondrial dysfunction, and reactivation of an inefficient fetal contractile gene program — and how this transition from adaptation to decompensated heart failure plays out morphologically with myocyte enlargement, interstitial fibrosis, and chamber remodeling.
- Hyperplasia: Increasing Cell Numbers in Health and Disease8:15Hyperplasia is the expansion of a cell population through increased mitotic activity, and it occurs only in cells capable of dividing, which is why neurons and cardiac myocytes cannot use this strategy. You will distinguish physiologic hyperplasia — hormonal, as in the female breast at puberty and pregnancy, and compensatory, as in liver regeneration after partial hepatectomy — from pathologic hyperplasia driven by excessive hormonal stimulation or growth factor signaling, such as endometrial hyperplasia from unopposed estrogen and benign prostatic hyperplasia from dihydrotestosterone. The lecture explores the molecular basis involving growth factor receptors, cell-cycle checkpoints, and stem cell pools, and explains why pathologic hyperplasia is a fertile soil for malignant transformation when the underlying stimulus is sustained and genetic damage accumulates. You will also see how viral infections like HPV produce reactive hyperplasia by encoding proteins that interfere with cell-cycle regulators p53 and Rb, and why this matters for cervical neoplasia screening.
- Atrophy: Mechanisms of Cellular Shrinkage9:10Atrophy is the shrinkage of cells through loss of cell substance, and when widespread, it leads to organ shrinkage that is clinically and grossly apparent. This lecture surveys the major causes — decreased workload as in immobilized limbs, denervation as in motor neuron disease, diminished blood supply, inadequate nutrition, loss of endocrine stimulation, pressure from adjacent tumors, and aging-related senile atrophy of the brain and heart. You will dive into the two major proteolytic systems that execute atrophy at the molecular level: the ubiquitin-proteasome pathway, where atrogenes such as atrogin-1/MAFbx and MuRF-1 tag proteins for degradation in response to glucocorticoids and inflammatory cytokines, and autophagy, in which cells digest their own organelles within autophagic vacuoles to liberate amino acids and lipids for survival. The lecture explains why atrophied cells are not dead but rather operating at a lower steady state, and how lipofuscin accumulation in atrophic cardiac myocytes produces brown atrophy of the heart.
- Metaplasia: Reversible Replacement of One Cell Type by Another8:43Metaplasia is the reversible change in which one differentiated cell type is replaced by another better suited to withstand a hostile environment, and it represents reprogramming of tissue stem cells rather than transdifferentiation of mature cells. You will explore the classic examples — squamous metaplasia of the ciliated bronchial epithelium in smokers, columnar metaplasia of esophageal squamous epithelium in chronic gastroesophageal reflux known as Barrett esophagus, and squamous metaplasia of the urothelium in chronic bladder stones or schistosomiasis. The lecture explains how cytokines, growth factors, and extracellular matrix components signal stem cells to switch transcription factor programs, including the role of retinoic acid and bone morphogenetic proteins, and why connective tissue metaplasia, such as myositis ossificans where skeletal muscle is replaced by bone, follows a parallel logic. Most critically, you will understand the dark side of metaplasia: when the inciting stimulus persists, the same signals can drive malignant transformation, making Barrett esophagus a precursor to adenocarcinoma and bronchial squamous metaplasia a precursor to squamous cell carcinoma.
- From Adaptation to Injury: Recognizing the Tipping Point10:58Adaptive responses have limits, and when the stress exceeds the adaptive capacity of a cell, injury supervenes — first reversible, then irreversible if the stimulus is severe or persistent enough. This lecture consolidates your understanding by mapping the continuum from normal homeostasis through adaptation to reversible injury, irreversible injury, and finally cell death, emphasizing the morphologic and functional thresholds that define each stage. You will revisit hypertrophic cardiomyopathy progressing to dilated heart failure, hyperplastic endometrium progressing to atypical hyperplasia and carcinoma, and metaplastic Barrett mucosa progressing to dysplasia and adenocarcinoma as concrete clinical illustrations of adaptation crossing into disease. The lecture introduces the conceptual framework that will guide the rest of your study: cells fail when their ability to maintain mitochondrial function, membrane integrity, protein homeostasis, and genomic stability is overwhelmed, and recognizing the early warning signs lets clinicians and pathologists intervene before the point of no return.
- Section 1 Quiz: Cellular Adaptations to Stress
- Roleplay: Cellular Adaptations to Stress
- Etiologies of Cell Injury: From Hypoxia to Aging9:00Cell injury results from a finite list of stressors, and this lecture catalogues them systematically so you can reason about any disease through this lens. You will learn how oxygen deprivation is the most common and clinically critical cause, manifesting either as hypoxia, where oxygen delivery is reduced but blood flow continues, or as ischemia, where blood flow itself is interrupted, depriving the tissue of both oxygen and substrates and creating a far more severe insult. The lecture then explores chemical agents ranging from glucose and salt at high concentrations to oxygen at high partial pressures, poisons such as cyanide and arsenic, alcohol, illicit drugs, and therapeutic agents that all damage cells through distinct mechanisms. You will also see how infectious agents from viruses to parasites, immunologic reactions including autoimmunity and hypersensitivity, genetic defects from single-gene mutations to chromosomal abnormalities, nutritional imbalances of deficiency and excess, physical agents including trauma, temperature extremes, radiation, and electrical shock, and finally the cumulative wear of aging all converge on a small set of biochemical mechanisms that the rest of this study will unpack.
- Hypoxia versus Ischemia: A Critical Distinction9:45Although clinicians often use hypoxia and ischemia interchangeably, the pathologist treats them as fundamentally different insults with different prognoses. In this lecture you will dissect the four major causes of hypoxia — inadequate oxygenation of blood from cardiorespiratory failure, reduced oxygen-carrying capacity from anemia or carbon monoxide poisoning, severe blood loss, and toxic blockade of cellular respiration as in cyanide poisoning — and contrast them with ischemia, in which arterial occlusion or venous outflow obstruction halts the delivery of oxygen, glucose, and removal of metabolic waste simultaneously. You will see why ischemic tissue dies faster and more completely than hypoxic tissue, and why anaerobic glycolysis can sustain a purely hypoxic cell for far longer than an ischemic one. The lecture grounds these concepts in the clinical scenarios of myocardial infarction, stroke, mesenteric ischemia, and the watershed zones of the brain and gut where collateral circulation is poorest, building the foundation for understanding ischemia-reperfusion injury later.
- ATP Depletion and Mitochondrial Damage9:12ATP is the energy currency of the cell, and its depletion below about 5 to 10 percent of normal triggers a cascade of failures that defines reversible injury and ultimately pushes cells into death. This lecture walks you through the consequences in order: failure of the sodium-potassium ATPase causes cellular swelling and endoplasmic reticulum dilation, anaerobic glycolysis depletes glycogen and accumulates lactic acid that lowers intracellular pH, ribosomes detach from the rough endoplasmic reticulum and protein synthesis falters, the calcium pump fails and cytosolic calcium rises catastrophically, and misfolded proteins trigger the unfolded protein response. You will then explore mitochondrial damage itself, including the opening of the mitochondrial permeability transition pore that collapses the membrane potential and releases cytochrome c into the cytosol, where it ignites the intrinsic apoptotic pathway. The lecture also covers how damaged mitochondria leak reactive oxygen species, creating a feedforward loop of injury, and why mitochondrial dysfunction sits at the center of nearly every form of cell death you will study.
- Oxidative Stress and Free Radical Injury11:02Reactive oxygen species are unavoidable byproducts of aerobic metabolism, and when their generation outpaces their removal, the resulting oxidative stress damages every class of biomolecule in the cell. You will learn how superoxide, hydrogen peroxide, and the highly reactive hydroxyl radical are generated by normal mitochondrial respiration, the Fenton reaction with iron, ionizing radiation, inflammation through the NADPH oxidase of neutrophils and macrophages, drug metabolism by cytochrome P450, and nitric oxide synthase activity that yields peroxynitrite. The lecture details the antioxidant defenses that normally keep these radicals in check — superoxide dismutase, catalase, the glutathione peroxidase system, vitamins E and C, and metal-binding proteins such as ceruloplasmin and transferrin — and explains what happens when they are overwhelmed. You will see how free radicals attack lipid membranes through peroxidation, oxidize proteins to disable enzymes, and cause DNA single- and double-strand breaks that trigger apoptosis or senescence, and how this mechanism underlies reperfusion injury, chemical toxicity, radiation damage, and aging itself.
- Membrane Damage and Calcium Influx9:58The plasma membrane and the membranes of intracellular organelles are the structural foundation of cellular life, and their breach is the hallmark of irreversible injury. In this lecture you will explore how reactive oxygen species peroxidize membrane phospholipids, how activated phospholipases driven by elevated cytosolic calcium degrade them directly, how cytoskeletal proteins are cleaved by calcium-activated proteases, and how lipid breakdown products themselves act as detergents on remaining membranes. You will trace the consequences of calcium influx as the master amplifier of injury: it activates phospholipases that destroy membranes, proteases that disrupt the cytoskeleton, endonucleases that fragment DNA, and ATPases that further deplete energy stores, while also opening the mitochondrial permeability transition pore. The lecture then explains how lysosomal membrane damage releases hydrolytic enzymes into the cytosol that digest the cell in necrosis, and why measurement of cytosolic enzymes like troponin, creatine kinase, and transaminases in serum is diagnostic of cellular membrane rupture.
- DNA Damage and Protein Misfolding9:52Cells live and die by the integrity of their genome and the fidelity of their proteome, and damage to either triggers protective programs that, when overwhelmed, end in cell death. You will learn how ionizing radiation, ultraviolet light, alkylating chemotherapy, reactive oxygen species, and replication errors generate single- and double-strand breaks, base modifications, and crosslinks in DNA, and how the ATM-ATR signaling network activates p53 to either pause the cell cycle for repair or initiate apoptosis when damage is irreparable. The lecture then turns to protein misfolding, examining how mutations, oxidative stress, heat, and impaired chaperone function fill the endoplasmic reticulum with misfolded proteins, triggering the unfolded protein response that attempts to restore homeostasis by attenuating translation, upregulating chaperones, and increasing degradation. When the unfolded protein response fails, ER stress pathways such as PERK, IRE1, and ATF6 switch from adaptive to apoptotic, and you will see how this mechanism underlies neurodegenerative diseases like Alzheimer, Parkinson, and Huntington as well as type 2 diabetes and inherited deficiencies like alpha-1-antitrypsin disease.
- Ischemia-Reperfusion Injury and Chemical Toxicity13:43Restoring blood flow to ischemic tissue saves lives, but it paradoxically inflicts further damage in a phenomenon called ischemia-reperfusion injury that has dramatic clinical implications for myocardial infarction, stroke, and organ transplantation. This lecture explains the four mechanisms — a burst of reactive oxygen species generated when oxygen returns to mitochondria damaged by ischemia, calcium overload as ion pumps suddenly try to restart, opening of the mitochondrial permeability transition pore, and inflammatory cell recruitment with complement activation that targets ischemia-modified self-antigens. You will then explore chemical toxicity through two paradigms: direct toxicity, where mercuric chloride and similar agents bind covalently to vital molecules and kill cells at the site of entry, and indirect toxicity through metabolic activation, exemplified by acetaminophen, which is converted by cytochrome P450 to NAPQI that depletes glutathione and damages hepatocytes, and carbon tetrachloride, which yields the trichloromethyl radical that initiates lipid peroxidation. These examples cement how molecular mechanisms translate into clinical poisoning syndromes.
- Section 2 Quiz: Causes and Mechanisms of Cell Injury
- Roleplay: Causes and Mechanisms of Cell Injury
- Reversible Cell Injury: Cellular Swelling and Fatty Change10:20Reversible injury is the early stage where cells are stressed but can still recover if the offending stimulus is removed, and recognizing it on histology gives clinicians a window for intervention before the point of no return. You will explore cellular swelling, also called hydropic change or vacuolar degeneration, as the universal first morphologic manifestation of injury caused by failure of ion pumps that allows sodium and water to accumulate, producing pale, swollen cytoplasm with small clear vacuoles that on gross examination renders organs pale, heavy, and turgid. The lecture then turns to fatty change, or steatosis, the abnormal accumulation of triglycerides within parenchymal cells, classically seen in the liver in alcoholism, obesity, diabetes, protein malnutrition, and certain hepatotoxins, and explained by imbalances among free fatty acid uptake, intracellular lipid synthesis, apolipoprotein production, and triglyceride export. You will learn the gross appearance of the enlarged, greasy, yellow liver, the microscopic distinction between microvesicular and macrovesicular steatosis, and the clinical significance of these reversible changes as warning signs that may progress to steatohepatitis, fibrosis, and cirrhosis.
- The Transition to Irreversible Injury7:13The boundary between reversible and irreversible injury is not a sharp line but a transition defined by two key events: the inability of mitochondria to recover even after the noxious stimulus is removed, and profound disturbance of membrane function, particularly the plasma membrane. In this lecture you will learn the morphologic markers of irreversibility, including severe mitochondrial vacuolization with calcium-rich amorphous densities visible on electron microscopy, extensive damage to plasma membranes and lysosomes that leaks digestive enzymes into the cytoplasm, and the leakage of intracellular proteins through the damaged membrane into the circulation, providing the basis for serum biomarkers of organ damage. The lecture explores the histologic features that define the dying cell — increased eosinophilia from loss of cytoplasmic RNA basophilia and increased binding of eosin to denatured proteins, the appearance of myelin figures from damaged membranes, and nuclear changes including pyknosis, karyorrhexis, and karyolysis that signal the point of no return. You will leave able to distinguish reversibly injured cells from dying cells under the microscope.
- Coagulative Necrosis: The Hallmark of Ischemic Death7:57Coagulative necrosis is the predominant pattern of cell death in solid organs after ischemia, and recognizing it on gross and microscopic examination is foundational for any pathologist or clinician interpreting an infarct. You will learn that in coagulative necrosis the underlying tissue architecture is preserved for days, because the acidic intracellular conditions generated by ischemic injury denature not only the structural proteins of the cell but also the lysosomal enzymes that would otherwise digest the dead cell. The result is a wedge-shaped, firm, pale region with sharp borders surrounded by a hyperemic rim of inflammation, microscopically revealing ghost outlines of cells with preserved cytoplasmic eosinophilia and lost nuclei. The lecture covers the classic clinical settings — myocardial infarction, renal infarction, splenic infarction, and most other solid organ infarcts — and explains why the brain is the major exception. You will also learn how neutrophils eventually infiltrate to digest the dead tissue, how macrophages phagocytose the debris, and how the lesion is ultimately replaced by a fibrous scar.
- Liquefactive Necrosis: When Tissue Becomes Pus or Soup9:56Liquefactive necrosis is the pattern in which dead tissue is digested into a viscous liquid mass, occurring whenever the activity of hydrolytic enzymes overwhelms the structural integrity of the tissue. You will learn the two principal contexts: bacterial and occasionally fungal infections, where massive accumulation of neutrophils releases lysosomal enzymes that liquefy tissue into pus and form abscesses, and central nervous system infarction, where the high lipid content of the brain and lack of substantial structural protein scaffolding causes ischemic neural tissue to dissolve rather than coagulate. The lecture explains the gross appearance of a creamy yellow abscess cavity or, in the brain, a fluid-filled cystic cavity surrounded by gliosis, and the microscopic finding of enzymatic destruction of the tissue with abundant nuclear debris and proteinaceous fluid. You will see how this pattern guides clinical management, from drainage of bacterial abscesses to imaging interpretation of cerebral infarcts evolving from acute coagulative changes to chronic cystic encephalomalacia.
- Caseous, Gangrenous, Fat, and Fibrinoid Necrosis8:00Several specialized patterns of necrosis carry strong etiologic implications, and recognizing them quickly narrows the differential diagnosis. You will learn caseous necrosis as the friable, white, cheesy material at the center of granulomas, classically in tuberculosis but also in some fungal infections, with a microscopic appearance of structureless eosinophilic debris surrounded by epithelioid macrophages, Langhans giant cells, and lymphocytes. Gangrenous necrosis is then explored as a clinical rather than histologic category, encompassing dry gangrene from ischemia, typically of a lower limb in diabetic vascular disease, and wet gangrene where superimposed bacterial infection adds liquefactive features. The lecture covers fat necrosis in two forms — enzymatic fat necrosis in acute pancreatitis where released lipases saponify triglycerides with calcium to produce chalky white deposits, and traumatic fat necrosis in the breast that can mimic malignancy. Finally you will see fibrinoid necrosis as the bright pink, smudgy deposition of immune complexes and fibrin in vessel walls, the hallmark of immune-mediated vasculitis and malignant hypertension.
- Clinical Correlates: Serum Markers of Cell Death10:54When cells die and their membranes rupture, intracellular proteins spill into the bloodstream and become measurable biomarkers that clinicians use to diagnose, prognosticate, and monitor disease. This lecture builds a unified framework for interpreting these markers by organ system: cardiac troponins I and T and creatine kinase MB for myocardial infarction, with attention to the kinetics of release and clearance; alanine and aspartate aminotransferases, alkaline phosphatase, and gamma-glutamyl transferase for hepatocellular and cholestatic patterns of liver injury; amylase and lipase for pancreatic acinar cell death; lactate dehydrogenase as a nonspecific but sensitive marker of cell turnover and necrosis; and creatinine for renal tubular injury reflecting loss of glomerular filtration. You will learn to read patterns of enzyme elevation as fingerprints of organ-specific injury, to correlate serum kinetics with the morphologic timeline of necrosis, and to recognize the limitations of these biomarkers when chronic disease, alternative sources, or analytical interferences complicate interpretation.
- Section 3 Quiz: Reversible and Irreversible Injury: Morphology of Necrosis
- Roleplay: Reversible and Irreversible Injury: Morphology of Necrosis
- Apoptosis Defined: Programmed, Energy-Dependent Cell Suicide8:54Apoptosis is the regulated, energy-dependent form of cell death by which the body eliminates unwanted, damaged, or potentially dangerous cells without inciting an inflammatory response, and understanding it is foundational for grasping cancer, autoimmunity, neurodegeneration, and embryologic development. You will learn to distinguish apoptosis from necrosis along every dimension — cell size shrinks rather than swells, the plasma membrane remains intact rather than ruptures, chromatin condenses into crescents along the nuclear envelope rather than dispersing, the cell fragments into membrane-bound apoptotic bodies rather than disintegrating, and neighboring phagocytes silently consume the remains without releasing damage-associated molecular patterns or triggering inflammation. The lecture frames apoptosis as a default execution program that every nucleated cell carries, normally restrained by survival signals and triggered when damage sensors, death receptors, or developmental cues override that restraint. You will see why so many diseases reflect either too much apoptosis, as in neurodegeneration and ischemic stroke, or too little, as in cancer and autoimmunity.
- The Intrinsic (Mitochondrial) Pathway of Apoptosis12:14The intrinsic pathway is the major route by which cells eliminate themselves in response to internal stress, including DNA damage, growth factor withdrawal, hypoxia, and unfolded protein accumulation, and it converges on the mitochondrion as the decision point between life and death. You will explore the central role of the BCL-2 family of proteins, which is divided into antiapoptotic guardians such as BCL-2, BCL-XL, and MCL-1 that protect mitochondrial outer membrane integrity, proapoptotic effectors BAX and BAK that oligomerize to permeabilize that membrane, and BH3-only sensors such as BIM, BID, BAD, PUMA, and NOXA that integrate stress signals and tip the balance. The lecture explains how mitochondrial outer membrane permeabilization releases cytochrome c into the cytosol, where it binds APAF-1 and procaspase-9 to form the apoptosome that activates caspase-9, which in turn activates executioner caspases. You will see how p53 connects DNA damage to this pathway by transcriptionally upregulating BH3-only proteins, and how cancers exploit overexpression of BCL-2, exemplified by follicular lymphoma's t(14;18) translocation, to escape apoptosis.
- The Extrinsic (Death Receptor) Pathway of Apoptosis9:36The extrinsic pathway delivers death signals from outside the cell through membrane receptors of the tumor necrosis factor receptor family, allowing the immune system and developmental cues to eliminate specific cells with precision. You will learn the canonical players — Fas (CD95) on target cells engaged by Fas ligand on cytotoxic T lymphocytes and natural killer cells, and tumor necrosis factor receptor 1 engaged by TNF — and how ligand binding triggers receptor trimerization and recruitment of adapter proteins like FADD through their death domains. The lecture walks you through formation of the death-inducing signaling complex that activates initiator caspase-8, which then directly cleaves executioner caspases or amplifies the signal by cleaving BID into truncated BID that engages the mitochondrial pathway, creating crosstalk between the two arms. You will also encounter cellular inhibitors of apoptosis such as FLIP, which competitively blocks caspase-8 activation, and see how this pathway underlies immune surveillance of virally infected and neoplastic cells as well as the killing of autoreactive lymphocytes that maintains self-tolerance.
- Execution Phase: Caspases, DNA Fragmentation, and Apoptotic Bodies9:37Once initiator caspases are activated, the execution phase carries out the rapid, orderly dismantling of the cell through a cascade of proteolysis that defines the morphology of apoptosis. You will learn how executioner caspases-3, -6, and -7 cleave more than a thousand substrates, including the inhibitor of caspase-activated DNase (ICAD), thereby releasing CAD to internucleosomal cleavage of DNA into the characteristic 180-200 base pair ladder visible on gel electrophoresis and detectable by the TUNEL assay. The lecture covers cleavage of lamins to collapse the nuclear envelope, cleavage of cytoskeletal proteins to fragment the cell into membrane-bound apoptotic bodies, and externalization of phosphatidylserine on the outer leaflet of the plasma membrane that serves as an eat-me signal. You will see how this signal is recognized by macrophage receptors and bridging molecules like MFG-E8, allowing efficient phagocytic clearance before membrane integrity is lost, which is the very feature that prevents inflammation and distinguishes apoptotic death from necrosis.
- Apoptosis in Physiology and Disease9:14Apoptosis is not just a response to injury but a constant, sculpting force in normal physiology, and its dysregulation underlies a vast spectrum of disease. You will explore physiologic apoptosis in embryogenesis, where it carves digits from webbed limb buds and remodels neural circuits; in hormonally dependent involution such as endometrial breakdown in the menstrual cycle, lactational regression of the breast, and prostatic atrophy after androgen withdrawal; in elimination of self-reactive lymphocytes during thymic negative selection; and in turnover of intestinal epithelium and neutrophils at the end of inflammation. The lecture then catalogues pathologic states defined by too much apoptosis, including neurodegenerative diseases like Alzheimer and Parkinson disease, ischemic injury at the penumbra of infarcts, viral hepatitis with hepatocyte apoptosis producing Councilman bodies, and graft-versus-host disease, alongside states defined by too little apoptosis, including cancers with p53 loss or BCL-2 overexpression and autoimmune diseases with defective deletion of self-reactive lymphocytes such as autoimmune lymphoproliferative syndrome.
- Section 4 Quiz: Apoptosis: The Programmed Cell Death Pathway
- Roleplay: Apoptosis: The Programmed Cell Death Pathway
- Autophagy: Self-Eating for Survival and Death14:35Autophagy is the lysosomal degradation of a cell's own components, serving primarily as a survival strategy during nutrient deprivation but also capable of executing cell death when sustained or excessive. You will learn the three forms — macroautophagy, the major pathway in which a double-membrane phagophore engulfs cytoplasmic contents to form an autophagosome that fuses with a lysosome; microautophagy, in which lysosomes directly invaginate cytoplasm; and chaperone-mediated autophagy, in which specific KFERQ-motif proteins are recognized by Hsc70 and translocated across the lysosomal membrane via LAMP-2A. The lecture details the molecular machinery, including initiation by the ULK1 complex regulated by mTOR and AMPK to sense nutrient and energy status, nucleation by the Beclin-1 PI3K complex, and elongation through the ATG conjugation systems that decorate the autophagosome with LC3-II. You will see how selective forms — mitophagy, xenophagy, and aggrephagy — clear damaged mitochondria, intracellular pathogens, and protein aggregates respectively, and how dysregulated autophagy contributes to neurodegeneration, infection, cancer, and aging.
- Necroptosis: Programmed Necrosis8:52Necroptosis is a regulated form of cell death that combines features of apoptosis, in that it is genetically programmed and signal-driven, with features of necrosis, in that it ruptures the plasma membrane and incites a powerful inflammatory response. You will trace the pathway from death receptor engagement, particularly TNF receptor 1, through assembly of a complex containing receptor-interacting protein kinases RIPK1 and RIPK3 when caspase-8 activity is blocked, leading to phosphorylation of the pseudokinase MLKL, which then oligomerizes and translocates to the plasma membrane to form pores that lyse the cell. The lecture explains how necroptosis serves as a backup death pathway when viruses encode caspase inhibitors to thwart apoptosis, and how the release of damage-associated molecular patterns from necroptotic cells drives pathology in ischemia-reperfusion injury, inflammatory bowel disease, multiple sclerosis, and pancreatitis. You will see why necrostatin inhibitors of RIPK1 are being investigated therapeutically and how necroptosis blurs the once-rigid divide between necrosis and apoptosis.
- Pyroptosis and Ferroptosis: Inflammatory and Iron-Dependent Death11:06Two additional regulated cell death programs have emerged as central to immunity and metabolism, and you will master both in this lecture. Pyroptosis is an inflammatory caspase-dependent death triggered when pattern recognition receptors and the NLR family form inflammasomes that activate caspase-1, which cleaves pro-IL-1-beta and pro-IL-18 into active cytokines and cleaves gasdermin D, whose N-terminal fragment forms membrane pores that release these cytokines and lyse the cell. You will see how pyroptosis defends against intracellular pathogens like Salmonella, Shigella, and Listeria, and how aberrant inflammasome activation drives gouty arthritis through monosodium urate crystals and atherosclerosis through cholesterol crystals. Ferroptosis is then introduced as an iron-dependent form of regulated necrosis driven by accumulation of lipid peroxides when the selenium-dependent enzyme GPX4 fails to keep up, often because cystine import via the system Xc- transporter is impaired. You will see its relevance to ischemia-reperfusion injury, neurodegeneration, and an emerging therapeutic strategy of inducing ferroptosis in cancer cells.
- Intracellular Accumulations: Lipids, Proteins, and Glycogen9:29Cells in disease often accumulate substances that they cannot metabolize, export, or degrade properly, and recognizing these accumulations is a daily task in diagnostic pathology. You will explore lipid accumulations beginning with steatosis revisited and extending to cholesterol deposits in atherosclerotic plaques, xanthomas of the skin and tendons in hyperlipidemia, and the cholesterol-laden foam cells that populate areas of inflammation and lipid storage disorders. The lecture then turns to protein accumulations including Russell bodies of immunoglobulin-distended plasma cells, alpha-1-antitrypsin globules in hepatocytes from misfolded protein retained in the endoplasmic reticulum, Mallory-Denk bodies of damaged hepatocyte intermediate filaments in alcoholic liver disease, and neurofibrillary tangles of hyperphosphorylated tau in Alzheimer disease. Glycogen accumulation is covered through the lens of the glycogen storage diseases such as Pompe and von Gierke disease and as a feature of poorly controlled diabetes mellitus in renal tubular epithelium and hepatocyte nuclei. You will leave able to interpret these accumulations as windows into specific metabolic and genetic pathologies.
- Pigments: Endogenous and Exogenous Deposits10:14Pigments are colored substances that accumulate in cells either from outside the body or from endogenous metabolism, and each tells a distinct pathologic story. You will learn the exogenous pigments first, focusing on carbon and silica inhaled into the lungs to produce anthracosis and silicosis, tattoo pigment phagocytosed by dermal macrophages, and heavy metals like lead and bismuth. The lecture then surveys endogenous pigments, beginning with lipofuscin, the wear-and-tear pigment of aging composed of polyunsaturated lipid peroxidation products that accumulates in long-lived postmitotic cells like neurons and cardiac myocytes, giving rise to brown atrophy. Melanin, produced by melanocytes from tyrosine via tyrosinase, is examined in its physiologic role of skin pigmentation and in pathologic settings of hyperpigmentation, vitiligo, and melanoma. Finally hemosiderin, the iron-storage pigment derived from ferritin aggregates, is explored in localized contexts such as bruises and chronic passive congestion of the lung and in systemic iron overload from hereditary hemochromatosis and repeated transfusions, where it damages the liver, pancreas, heart, and endocrine organs.
- Pathologic Calcification: Dystrophic and Metastatic10:14Pathologic calcification is the abnormal deposition of calcium salts together with smaller amounts of iron, magnesium, and other minerals, and it falls into two distinct categories with very different clinical implications. You will learn dystrophic calcification as deposition that occurs in dead or dying tissue despite normal serum calcium levels, exemplified by calcification of atherosclerotic plaques, aging or damaged heart valves producing aortic stenosis, tuberculous caseous necrosis that becomes radiographically visible, psammoma bodies of papillary thyroid carcinoma, serous ovarian tumors, and meningiomas, and fat necrosis in the breast and pancreas. The lecture then explains metastatic calcification, which occurs in otherwise normal tissues when hypercalcemia is present, with causes including primary hyperparathyroidism, paraneoplastic syndromes from parathyroid hormone-related protein, vitamin D intoxication, milk-alkali syndrome, sarcoidosis, and bone destruction from metastases or multiple myeloma. You will learn the predilection sites — gastric mucosa, kidneys, lungs, systemic arteries, and pulmonary veins where local alkalinity from acid secretion or carbon dioxide elimination favors precipitation — and the clinical consequences of nephrocalcinosis and pulmonary calcification.
- Section 5 Quiz: Other Forms of Cell Death and Intracellular Accumulations
- Roleplay: Other Forms of Cell Death and Intracellular Accumulations
Requirements
- Basic understanding of cell biology including organelles and their functions
- Foundational knowledge of biochemistry covering enzymes, ATP, and metabolic pathways
- Familiarity with general histology and basic tissue types
- Introductory exposure to human anatomy and physiology
- Comfort with medical terminology used in basic science courses
Description
This course contains the use of artificial intelligence.
Every disease begins at the level of the cell, and understanding how cells adapt, get injured, and die is the foundation upon which all of pathology — and ultimately all of clinical medicine — is built. From the bulked-up heart of a hypertensive patient to the caseous necrosis at the heart of a tuberculous granuloma, the patterns you learn here are the same patterns you will see on every histology slide, every imaging study, and every autopsy for the rest of your career. This course distills the most rigorous concepts of cellular pathology into engaging, visually rich lessons that will sharpen your reasoning and prepare you for board examinations and clinical rotations alike.
You will begin with the four cellular adaptations to stress — hypertrophy, hyperplasia, atrophy, and metaplasia — exploring their physiologic and pathologic forms, the molecular signaling pathways that drive them, and the clinical contexts in which they tip into disease. From there you will examine the causes and mechanisms of cell injury, including the critical distinction between hypoxia and ischemia, the central role of ATP depletion and mitochondrial dysfunction, the chemistry of oxidative stress and free radical injury, the consequences of membrane damage and calcium influx, and the protective programs triggered by DNA damage and protein misfolding through the unfolded protein response. You will then master the morphology of reversible injury through cellular swelling and fatty change, contrasted with the irreversible patterns of coagulative, liquefactive, caseous, gangrenous, fat, and fibrinoid necrosis.
The course continues with a deep dive into apoptosis, covering the intrinsic mitochondrial pathway with its BCL-2 family rheostat, the extrinsic death receptor pathway with its FADD and caspase-8 cascade, the execution phase with DNA fragmentation and phosphatidylserine flipping, and the roles of apoptosis in development, immunity, cancer, and neurodegeneration. You will also explore newer forms of regulated cell death including autophagy, necroptosis, pyroptosis, and ferroptosis, and finish with the intracellular accumulations of lipids, proteins, glycogen, pigments, and pathologic calcifications that shape diagnostic histopathology. Medical, dental, and biomedical science students preparing for examinations such as USMLE Step 1, pathology residents reviewing core concepts, and clinicians wanting a refresher will all find the content rigorous yet approachable.
What sets this course apart is its tight integration of mechanism with morphology and clinical correlation — every concept is grounded in real disease scenarios you will encounter in practice, and every pattern is connected back to the molecular events that produced it. Enroll today to build a rock-solid foundation in cellular pathology that will pay dividends across every system, every organ, and every patient encounter for the rest of your career.
Who this course is for:
- Medical students preparing for pathology coursework and USMLE Step 1 examinations
- Dental students studying general and oral pathology fundamentals
- Pathology residents seeking a structured review of core cellular pathology concepts
- Biomedical science and graduate students studying cellular responses to injury
- Practicing clinicians and allied health professionals refreshing their foundational pathology knowledge